COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,199 Articles (22,713 medRxiv, 8,486 bioRxiv)

Most recent first Previous |  Page 1449: Articles 14481-14490  | Next

Impact of long-term care facility size on preparedness and adherence to infection prevention and control guidance for the mitigation of COVID-19
Wachholz, P. A., Melo, R. C. d., Jacinto, A. F., Villas Boas, P. J. F.
10.1101/2021.06.12.21258774 — Posted: 2021-06-14
IMPACT OF COVID-19 PANDEMIC ON SICKNESS ABSENCE FOR MENTAL ILL HEALTH IN NATIONAL HEALTH SERVICE STAFF
van der Plaat, D., Edge, R., Coggon, D., van Tongersen, M., Muiry, R., Parsons, V., Cullinan, P., Madan, I.
10.1101/2021.06.09.21258629 — Posted: 2021-06-14
The prevalence, incidence, prognosis and risk factors for depression and anxiety in a UK cohort during the COVID-19 pandemic
Jia, R., Ayling, K., Chalder, T., Massey, A., Gasteiger, N., Broadbent, E., Coupland, C., vedhara, k.
10.1101/2021.06.11.21258750 — Posted: 2021-06-14
Reopening International Borders without Quarantine: Contact Tracing Integrated Policy against COVID-19
Yu, Z., Zhu, X., Liu, X., Chen, X., Wei, T., Yuan, H.-Y., Xu, Y., Zhu, R., He, H., Wang, H., Wong, M.-s., Jia, P., Shi, W.-z., Chen, W.
10.1101/2021.06.10.21258672 — Posted: 2021-06-14
NMPylation and de-NMPylation of SARS-CoV-2 Nsp9 by the NiRAN domain
Wang, B., Svetlov, D., Artsimovitch, I.
10.1101/2021.06.13.448258 — Posted: 2021-06-14
Regulatory dissection of the severe COVID-19 risk locus introgressed by Neanderthals
Jagoda, E., Marnetto, D., Montinaro, F., Richard, D., Pagani, L., Capellini, T. D.
10.1101/2021.06.12.448149 — Posted: 2021-06-14
COVID-eVax, an electroporated plasmid DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain, elicits protective immune responses in animal models of COVID-19
Conforti, A., Marra, E., Palombo, F., Roscilli, G., Rava, M., Fumagalli, V., Muzi, A., Maffei, M., Luberto, L., Lione, L., Salvatori, E., Compagnone, M., Pinto, E., Pavoni, E., Bucci, F., Vitagliano, G., Stoppoloni, D., Pacello, M. L., Cappelletti, M., Ferrara, F. F., D'Acunto, E., Chiarini, V., Arriga, R., Nyska, A., Di Lucia, P., Marotta, D., Bono, E., Giustini, L., Sala, E., Perucchini, C., Paterson, J., Ryan, K. A., Challis, A., Matusali, G., Colavita, F., Caselli, G., Criscuolo, E., Clementi, N. A., Mancini, N., Gross, R., Siedel, A., Wettstein, L., Munch, J., Donnici, L., Conti, M., De Francesco, R., Kuka, M., Ciliberto, G., Castilletti, C., Capobianchi, M. R., Ippolito, G., Guidotti, L., Rovati, L., Iannacone, M., Aurisicchio, L.
10.1101/2021.06.14.448343 — Posted: 2021-06-14
Safety, Immunogenicity, and Efficacy of a COVID-19 Vaccine (NVX-CoV2373) Co-administered With Seasonal Influenza Vaccines
Heath, P., Toback, S., Galiza, E., Cosgrove, C., Galloway, J., Goodman, A. L., Swift, P. A., Rajaram, S., Graves-Jones, A., Edelman, J., Burns, F., Minassian, A. M., Cho, I., Kumar, L., Plested, J. S., Rivers, E. J., Robertson, A., Dubovsky, F., Glenn, G.
10.1101/2021.06.09.21258556 — Posted: 2021-06-13 Discussion: Offsite
Glycolytic inhibitor 2-Deoxy-D-glucose attenuates SARS-CoV-2 multiplication in host cells and weakens the infective potential of progeny virions
Bhatt, A. N., Kumar, A., Rai, Y., Kumari, N., Vedagiri, D., Harshan, K. H., Chinnadurai, V., Chandna, S.
10.1101/2021.06.12.448175 — Posted: 2021-06-13
Anti-SARS-CoV-2 potential of Cissampelos pareira L. identified by Connectivity map-based analysis and in vitro studies
Haider, M., Anand, V., Dholakia, D., Enayathullah, M. G., Parekh, Y., Ram, S., Kumari, S., K, A., Bokara, K. K., Sharma, U., Prasher, B., Mukerji, M.
10.1101/2021.06.11.448155 — Posted: 2021-06-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).